Alan Leshner

The Scientist Date: April 26, 1997 THE SCIENTIST® The Newspaper for the Life Sciences Professional (609)-786-7207 For Fast Service "It's obviously very important to stay up to date, and since I define my field broadly, THE SCIENTIST has the most comprehensive coverage of a wide range of topics. THE SCIENTIST is a good way to stay connected with policy, policymakers, and the general scientific community." ALAN LESHNER Director National Institute On Drug Abuse National Institutes Of Heal

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: April 26, 1997

ALAN LESHNER
Director
National Institute On Drug Abuse
National Institutes Of Health
Rockville, MD

By training, Leshner is a neuroscientist and psychologist. He has conducted research on the relationship between biology and behavior. And it is because of this research focus and the evolution of the neuroscience of drug abuse that his interest grew in that direction. By working with drug abuse professionals, the general public, and policymakers, Leshner is striving to ensure that the science supported by NIDA is not only useful but also used.

A reader of THE SCIENTIST, Leshner says: "It's obviously very important to stay up to date and since I define my field broadly, THE SCIENTIST has the most comprehensive coverage of a wide range of topics. THE SCIENTIST is a good way to stay connected with policy, policymakers, and the general scientific community."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies